Abiopharma

🔍 ENO Robert Paul (Executive)

Company: HeartBeam, Inc. (BEAT)

Report Date: 2026-04-16

Detailed Transactions and Holdings:

• Acquired 12,500 shares of Common Stock at $0.8 per share (Direct)
  Date: 2026-04-16 | Code: P | equity_swap_involved: 0 | shares_owned_after: 36,742.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.
• F2: Includes 23,333 RSUs which have vested as per the Form 4 filed on October 2, 2025.